Efficacy and Safety of Halobetasol Propionate 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis in a Hispanic Population: Post Hoc Analysis of Two Phase 3 Randomized Controlled Trials

Main Article Content

SR Desai
B Glick
JQ Del Rosso
T Lin


Halobetasol, Psoriasis


Abstract not available.


1. Nestle FO, et al. N Engl J Med. 2009;361(5):496-509.
2. Menter A, et al. J Am Acad Dermatol. 2009;60(4):643-659.
3. Sugarman JL, et al. Cutis. 2019;103(2):11-116.
4. Green LJ, et al. J Drugs Dermatol. 2018;17(10):1062-1069.

Most read articles by the same author(s)